Recent News

By Region: North America

First Smallpox Vaccine for Special Populations Delivered Under Project BioShield

Delivery to the Strategic National Stockpile of the first 1 million doses of the nation’s first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

July 15, 2010
| Filed under North America and Countermeasures
Share

UTSA granted patent for vaccine research

University of Texas at San Antonio scientists have been granted a patient for developing a process to create a vaccine against a disease called tularemia. It’s an infectious agent that could be deadly in the hands of terrorists.

July 14, 2010
| Filed under North America and Research
Share

New York National Guard to Stand Up Homeland Response Force

The New York National Guard is taking the lead in Department of Defense and National Guard efforts to establish the Chemical, Biological, Radiological, Nuclear and High Yield Explosive (CBRNE) Task Force, to deal with chemical, biological, radiological and high-yield explosive incidents.

July 14, 2010
| Filed under North America and Countermeasures
Share

Wave Technology Studied For WMD Detection

Scientists in New York are preparing new detection technology that uses terahertz wave technology to “see through” apparel and packages that could be hiding biological or chemical weapons materials, United Press International reported Monday.

July 14, 2010
| Filed under North America, Biological Weapons, and Research
Share

U.S. Receives 1 Million Smallpox Vaccine Doses

The United States has received 1 million doses of a new smallpox vaccine, Imvamune, for the Strategic National Stockpile, Danish manufacturer Bavarian Nordic announced yesterday. Imvamune was created under Project Bioshield, a federal program to boost U.S. defenses against biological weapons and other WMD agents by financing the development and acquisition of medical countermeasures. Bavarian Read More »